Molecular detection (k-ras) of exfoliated tumour cells in the pelvis is a prognostic factor after resection of rectal cancer?

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Kristensen, Annette Torgunrud ^a,b   Wiig, Johan N ^a   Larsen, Stein G ^a   Giercksky, Karl Erik ^a,b   Ekstrøm, Per O ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAPILLARY ELECTROPHORESIS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; PERITONEUM LAVAGE; PILOT STUDY; POSTOPERATIVE CARE; PROGNOSIS; RECTUM CANCER; RECTUM SURGERY; SURVIVAL TIME; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; NEOPLASM; ONCOGENE RAS; PATHOLOGY; PELVIS; RECTUM TUMOR; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PELVIS; PILOT PROJECTS; RECTAL NEOPLASMS; RECURRENCE; TREATMENT OUTCOME;

EID: 50649092113     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-213     Document Type: Article

References (41)

1. The Cancer Registry of Norway 2006 http://www.kreftregisteret.no/
2. Wibe A Carlsen E Dahl O Tveit KM Weedon-Fekjaer H Hestvik UE Wiig JN Nationwide quality assurance of rectal cancer treatment Colorectal Dis 2006, 8:224-229 10.1111/j.1463-1318.2005.00924.x 16466564
3. Heald RJ Husband EM Ryall RD The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982, 69:613-616 10.1002/ bjs.1800691019 6751457
4. Larsen SG Wiig JN Dueland S Giercksky KE Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer Journal of Surgical Oncology (EJSO) 2008, 34:410-417 10.1016/ j.ejso.2007.05.012
5. Wiig JN Carlsen E Søreide O Mesorectal excision for rectal cancer: A view from Europe Semin Surg Oncol 1998, 15:78-86 10.1002/ (SICI)1098-2388(199809)15:2<78::AID-SSU4>3.0.CO;2-2 9730413
6. Herrera-Ornelas L Justiniano J Castillo N Petrelli NJ Stulc JP Mittelman A Metastases in small lymph nodes from colon cancer Arch Surg 1987, 122:1253-1256 3675188
7. Basha G Penninckx F Exfoliated tumour cells and locally recurrent colorectal cancer Acta Chir Belg 1996, 96:66-70 8686405
8. Tong YK Lo YM Diagnostic developments involving cell-free (circulating) nucleic acids Clin Chim Acta 2006, 363:187-196 10.1016/ j.cccn.2005.05.048 16126188
9. Kanellos I Zacharakis E Kanellos D Pramateftakis MG Betsis D Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer Colorectal Dis 2006, 8:436-440 10.1111/j.1463-1318.2006.00991.x 16684089
10. Ziegler A Zangemeister-Wittke U Stahel RA Circulating DNA: A new diagnostic gold mine? Cancer Treat Rev 2002, 28:255-271 10.1016/ S0305-7372(02)00077-4 12435372
11. Fearon ER Vogelstein B A genetic model for colorectal tumorigenesis Cell 1990, 61:759-767 10.1016/0092-8674(90)90186-I 2188735
12. Breivik J Lothe RA Meling GI Rognum TO Børresen-Dale AL Gaudernack G Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors Int J Cancer 1997, 74:664-669 10.1002/ (SICI)1097-0215(19971219)74:6<664::AID-IJC18>3.0.CO;2-5 9421366
13. Russo A Bazan V Agnese V Rodolico V Gebbia N Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies Ann Oncol 2005, 16 Suppl 4:iV44-iv49. iv44 iv49 10.1093/annonc/mdi907
14. Boughdady IS Kinsella AR Haboubi NY Schofield PF K-ras gene mutations in adenomas and carcinomas of the colon Surg Oncol 1992, 1:275-282 10.1016/ 0960-7404(92)90088-3 1341261
15. Servomaa K Kiuru A Kosma VM Hirvikoski P Rytomaa T p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women Mol Pathol 2000, 53:24-30 1186898 10884918 10.1136/mp.53.1.24
16. Frattini M Balestra D Suardi S Oggionni M Alberici P Radice P Costa A Daidone MG Leo E Pilotti S Bertario L Pierotti MA Different genetic features associated with colon and rectal carcinogenesis Clin Cancer Res 2004, 10:4015-4021 10.1158/1078-0432.CCR-04-0031 15217933
17. American Joint Committee on Cancer 2006 http://www.cancerstaging.org/
18. Wiig JN Larsen SG Dueland S Giercksky KE Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence Colorectal Dis 2008, 10:48-57 10.1111/j.1463-1318.2008.01576.x 18028472
19. Rozen S Skaletsky H Primer3 on the WWW for general users and for biologist programmers Methods Mol Biol 2000, 132:365-386 10547847
20. Bjørheim J Gaudernack G Giercksky KE Ekstrøm PO Direct identification of all oncogenic mutants in K-ras exon 1 by cycling temperature capillary electrophoresis Electrophoresis 2003, 24:63-69 10.1002/elps.200390032 12652573
21. Wu JS Fazio VW Management of rectal cancer J Gastrointest Surg 2004, 8:139-149 10.1016/j.gassur.2003.10.011 15036189
22. George S Primrose J Talbot R Smith J Mullee M Bailey D du BC Jordan H Will Rogers revisited: Prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists Br J Cancer 2006, 95(7):841-847 10.1038/ sj.bjc.6603352 16969342
23. Johnson PM Porter GA Ricciardi R Baxter NN Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer J Clin Oncol 2006, 24:3570-3575 10.1200/JCO.2006.06.8866 16877723
24. Lloyd JM McIver CM Stephenson SA Hewett PJ Rieger N Hardingham JE Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells Clin Cancer Res 2006, 12:417-423 10.1158/1078-0432.CCR-05-1473 16428481
25. Hase K Ueno H Kuranaga N Utsunomiya K Kanabe S Mochizuki H Intraperitoneal exfoliated cancer cells in patients with colorectal cancer Dis Colon Rectum 1998, 41:1134-1140 10.1007/BF02239435 9749497
26. Lennon AM Mulcahy HE Hyland JM Lowry C White A Fennelly D Murphy JJ O'Donoghue DP Sheahan K Peritoneal involvement in stage II colon cancer Am J Clin Pathol 2003, 119:108-113 10.1309/J6BDTWM2M792TN2V 12520705
27. Wang JY Hsieh JS Chang MY Huang TJ Chen FM Cheng TL Alexandersen K Huang YS Tzou WS Lin SR Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers World J Surg 2004, 28:721-726 15185002
28. Vogel P Ruschoff J Kummel S Zirngibl H Hofstadter F Hohenberger W Jauch KW Prognostic value of microscopic peritoneal dissemination: Comparison between colon and gastric cancer Dis Colon Rectum 2000, 43:92-100 10.1007/BF02237250 10813130
29. Kanellos I Demetriades H Zintzaras E Mandrali A Mantzoros I Betsis D Incidence and prognostic value of positive peritoneal cytology in colorectal cancer Dis Colon Rectum 2003, 46:535-539 10.1007/ s10350-004-6595-0 12682550
30. Wibe A Moller B Norstein J Carlsen E Wiig JN Heald RJ Langmark F Myrvold HE Soreide O A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit Dis Colon Rectum 2002, 45:857-866 10.1007/s10350-004-6317-7 12130870
31. Wibe A Eriksen MT Syse A Tretli S Myrvold HE Soreide O Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level Br J Surg 2005, 92:217-224 10.1002/ bjs.4821 15584060
32. Kristensen AT Bjørheim J Minarik M Giercksky KE Ekstrøm PO Detection of mutations in exon 8 of TP53 by temperature gradient 96-capillary array electrophoresis Biotechniques 2002, 33:650-653 12238774
33. Umpleby HC Fermor B Symes MO Williamson RC Viability of exfoliated colorectal carcinoma cells Br J Surg 1984, 71:659-663 10.1002/ bjs.1800710902 6478151
34. Skipper D Cooper AJ Marston JE Taylor I Exfoliated cells and in vitro growth in colorectal cancer Br J Surg 1987, 74:1049-1052 10.1002/ bjs.1800741130 3690235
35. Barry EL Baron JA Grau MV Wallace K Haile RW K-ras mutations in incident sporadic colorectal adenomas Cancer 2006, 106:1036-1040 10.1002/ cncr.21721 16456810
36. Smakman N Borel R I Voest EE Kranenburg O Control of colorectal metastasis formation by K-Ras Biochim Biophys Acta 2005, 1756:103-114 16098678
37. Al Mulla F MacKenzie EM Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations J Pathol 2001, 195:549-556 10.1002/path.995 11745690
38. Andreyev HJ Norman AR Cunningham D Oates J Dix BR Iacopetta BJ Young J Walsh T Ward R Hawkins N Beranek M Jandik P Benamouzig R Jullian E Laurent-Puig P Olschwang S Muller O Hoffmann I Rabes HM Zietz C Troungos C Valavanis C Yuen ST Ho JW Croke CT O'Donoghue DP Giaretti W Rapallo A Russo A Bazan V Tanaka M Omura K Azuma T Ohkusa T Fujimori T Ono Y Pauly M Faber C Glaesener R de Goeij AF Arends JW Andersen SN Lovig T Breivik J Gaudernack G Clausen OP De Angelis PD Meling GI Rognum TO Smith R Goh HS Font A Rosell R Sun XF Zhang H Benhattar J Losi L Lee JQ Wang ST Clarke PA Bell S Quirke P Bubb VJ Piris J Cruickshank NR Morton D Fox JC Al Mulla F Lees N Hall CN Snary D Wilkinson K Dillon D Costa J Pricolo VE Finkelstein SD Thebo JS Senagore AJ Halter SA Wadler S Malik S Krtolica K Urosevic N Kirsten ras mutations in patients with colorectal cancer: The 'RASCAL II' study Br J Cancer 2001, 85:692-696 10.1054/ bjoc.2001.1964 11531254
39. Lee JC Wang ST Lai MD Lin YJ Yang HB K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers Anticancer Res 1996, 16:3839-3844 9042267
40. Benhattar J Losi L Chaubert P Givel JC Costa J Prognostic significance of K-ras mutations in colorectal carcinoma Gastroenterology 1993, 104:1044-1048 8462792
41. Lievre A Bachet JB Le Corre D Boige V Landi B Emile JF Cote JF Tomasic G Penna C Ducreux M Rougier P Penault-Llorca F Laurent-Puig P KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer Cancer Res 2006, 66:3992-3995 10.1158/ 0008-5472.CAN-06-0191 16618717